| NCT ID | NCT03241810 |
| Title | Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer (SHERBOC) |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | yes |
| Sponsors | Merrimack Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |